Immunother Limited Company Reports Filing of New Intellectual Property

Immunother Limited Company, a preclinical stage biotech company focused on novel treatments to prevent and treat autoimmune conditions and cancer, files patent for HIV and organ transplantation technologies. On January 4th, 2011, Immunother Limited Company (ISIN: CN1000207834) filed provisional patent applications for its HIV vaccine and organ transplantation technologies. Both of these technologies have emerged from recent developments in Network Theory as applied to the immune system, and are closely related to each other at the level of the fundamental science. This was soon followed by a patent application for its technology.